Eupraxia Pharmaceuticals stock falls after pricing $55M public offering
Source: SeekingAlpha
2026-02-19 05:44:49 ET
Read the full article on Seeking Alpha
For further details see:
Eupraxia Pharmaceuticals stock falls after pricing $55M public offering
Eupraxia Pharmaceuticals Inc.
NASDAQ: EPRX
EPRX Trading
-2.69% G/L:
$7.60 Last:
5,335 Volume:
$7.60 Open:
EPRX Latest News
February 20, 2026 03:10:55 pm
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
February 19, 2026 02:18:17 am
Eupraxia Pharmaceuticals Announces Pricing of US$55 Million Public Offering of Common Shares and Pre-Funded Warrants
EPRX Stock Data
$435,556,805
34,844,532
4.18%
8
N/A
Biotechnology & Life Sciences
Healthcare
CA
Victoria
